Cargando…

Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella

Diarrheal diseases still remain health problem worldwide and out of many bacteria responsible for, Shigella and pathogenic Escherichia cause the most diarrheas in the world. Shigellacause bacterial dysenteries and shigellosis through invasion where the most effective proteins for pathogenesis is Ipa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalouie, Farzane, Mousavi, Seyed Latif, Nazarian, Shahram, Amani, Jafar, Pourfarzam, Poune
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shiraz University 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640892/ https://www.ncbi.nlm.nih.gov/pubmed/29071279 http://dx.doi.org/10.22099/mbrc.2017.4081

Ejemplares similares

Preparation of chitosan nanoparticle containing recombinant StxB antigen of EHEC and evaluation its immunogenicity in BALB/c mice
por: Almasian, Pegah, et al.
Publicado: (2018)

Immunogenic Potency of Formalin and Heat Inactivated E. coli O157:H7 in Mouse Model Administered by Different Routes
por: Arshadi, Nasim, et al.
Publicado: (2020)

Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
por: Arshadi, Nasim, et al.
Publicado: (2022)

Identification and evaluation of novel vaccine candidates against Shigella flexneri through reverse vaccinology approach
por: Hajialibeigi, Abolfazl, et al.
Publicado: (2021)

Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC
por: Harutyunyan, Shushan, et al.
Publicado: (2020)

Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial
por: Girardi, Petra, et al.
Publicado: (2022)

A CssA, CssB and LTB chimeric protein induces protection against Enterotoxigenic Escherichia coli
por: Bagheri, Samane, et al.
Publicado: (2014)

In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications
por: Amani, Jafar, et al.
Publicado: (2009)

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice
por: Hosseini, Zahra Sadat, et al.
Publicado: (2018)

An in silico Design, Expression and Purification of a Chimeric Protein as an Immunogen Candidate Consisting of IpaD, StxB, and TolC Proteins from Shigella spp.
por: Fathi, Javad, et al.
Publicado: (2022)

Recombinant expression of SARS-CoV-2 receptor binding domain (RBD) in Escherichia coli and its immunogenicity in mice
por: Rahbar, Zahra, et al.
Publicado: (2022)

Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus
por: Das, Jai K, et al.
Publicado: (2013)

Presenting a rapid method for detection of Bacillus cereus, Listeria monocytogenes and Campylobacter jejuni in food samples
por: Razei, Ali, et al.
Publicado: (2017)

Detection of E. coli O157:H7 and Shigella dysenteriae toxins in clinical samples by PCR-ELISA
por: Amani, Jafar, et al.
Publicado: (2015)

Immunogenicity and protective efficacy of enterotoxigenic Escherichia coli (ETEC) total RNA against ETEC challenge in a mouse model
por: Liu, Mandi, et al.
Publicado: (2020)

EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7
por: Rad, Hamid Sedighian, et al.
Publicado: (2013)

Immunogenicity of a Fusion Protein Comprising Coli Surface Antigen 3 and Labile B Subunit of Enterotoxigenic Escherichia coli
por: Alerasol, Masoome, et al.
Publicado: (2014)

Immunogenicity of enterotoxigenic Escherichia coli outer membrane vesicles encapsulated in chitosan nanoparticles
por: Noroozi, Nafiseh, et al.
Publicado: (2018)

Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice
por: Gheybi, Elaheh, et al.
Publicado: (2018)

Antigenicity and immunogenicity of SARS-CoV-2 surface glycoprotein fragment in CHO cells
por: Karimi, Sahar, et al.
Publicado: (2023)

Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
por: Hosangadi, Divya, et al.
Publicado: (2019)

Passive immunization by recombinant ferric enterobactin protein (FepA) from Escherichia coli O157
por: Larrie-Bagha, Seyed Mehdi, et al.
Publicado: (2013)

Immunoreactivity evaluation of a new recombinant chimeric protein against Brucella in the murine model
por: Abdollahi, Abbas, et al.
Publicado: (2016)

Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
por: Rezaei, Amir, et al.
Publicado: (2022)

Crystal Structure of EHEC Intimin: Insights into the Complementarity between EPEC and EHEC
por: Yi, Yong, et al.
Publicado: (2010)

Protective Immunity Against Enterotoxigenic Escherichia coli by Oral Vaccination of Engineered Lactococcus lactis
por: Ahmadi Rouzbahani, Homa, et al.
Publicado: (2021)

Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries
por: Anderson, John D., et al.
Publicado: (2019)

Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
por: Fakoor, Mohammad Hadi, et al.
Publicado: (2020)

Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries
por: Anderson, John D., et al.
Publicado: (2019)

Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7
por: Doavi, Tahere, et al.
Publicado: (2016)

Immunogenicity of Cork and Loop Domains of Recombinant Baumannii acinetobactin Utilization Protein in Murine Model
por: Esmaeilkhani, Hamid, et al.
Publicado: (2019)

Enterohemorrhagic E. coli (EHEC) pathogenesis
por: Nguyen, Y, et al.
Publicado: (2012)

Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)
por: Norton, Elizabeth B., et al.
Publicado: (2015)

Correction: Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)
Publicado: (2015)

The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin
por: Westcott, Marlena M., et al.
Publicado: (2023)

The immunogenicity of chimeric antibodies
Publicado: (1989)

Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge
por: Harro, Clayton, et al.
Publicado: (2019)

Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development
por: Mani, Sachin, et al.
Publicado: (2019)

Maternal Vaccination. Immunization of Sows during Pregnancy against ETEC Infections
por: Matías, Jose, et al.
Publicado: (2017)

Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
por: Mancini, Francesca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dm1674kmihq8tirfgdiuvnkre4